首页 > 最新文献

Urogynecology (Hagerstown, Md.)最新文献

英文 中文
Phenotype Variability in Interstitial Cystitis Clinical Trial Recruitment. 间质性膀胱炎临床试验招募的表型变异性。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-29 DOI: 10.1097/SPV.0000000000001759
Ryan Wong, Emmaline Woodworth, Charles Wood, Sarah A Adelstein, Annah J Vollstedt

Importance: There is a need to understand phenotype-specific therapies for interstitial cystitis/bladder pain syndrome (IC/BPS) at the clinical trial level to move beyond trial-and-error treatment approaches.

Objective: The objective of this study was to characterize IC/BPS clinical trials that incorporate patient phenotype into the eligibility criteria in accordance with the American Urological Association (AUA) guidelines.

Study design: Registered IC/BPS clinical trials were identified from ClinicalTrials.gov. Trials were included if they enrolled patients with IC/BPS and addressed pain-related outcomes. Trials were assessed for phenotype recognition and categorized by intervention type, funding source, and registration date relative to the AUA's 2015 IC/BPS guidelines for initial phenotype recognition.

Results: Out of 170 trials, 37 (21.8%) included phenotype stratification. The majority focused on bladder-centric presentations. Men were underrepresented in IC/BPS clinical trials. Phenotypic stratification was more frequently reported in industry-funded trials compared with those without industry support (40.5% vs 16.5%, P =0.0031). Trials registered after the 2015 AUA guideline update showed greater phenotype inclusion, though this was not statistically significant (26.6% vs 15.8%). Therapeutic trials comprised the majority of trials. Stratification appeared more often in physical therapy and psychosocial trials at 40% and in drug studies at 34.3%. Intravesical instillation and injection trials showed lower rates at 19.6% and 13.0%, respectively.

Conclusions: Failure to incorporate IC/BPS phenotypes into trial design limits the ability to evaluate treatments within the context of real-world symptom variability. Bridging this methodological gap is essential to ensure that clinical research supports the development of more targeted and effective therapies.

重要性:有必要在临床试验水平上了解间质性膀胱炎/膀胱疼痛综合征(IC/BPS)的表型特异性治疗方法,以超越试错治疗方法。目的:本研究的目的是根据美国泌尿协会(AUA)指南,将患者表型纳入资格标准的IC/BPS临床试验的特征。研究设计:已注册的IC/BPS临床试验从ClinicalTrials.gov网站上确定。如果纳入了IC/BPS患者并处理了与疼痛相关的结果,则纳入了试验。对试验进行表型识别评估,并根据干预类型、资金来源和注册日期(相对于AUA 2015 IC/BPS初始表型识别指南)对试验进行分类。结果:在170项试验中,37项(21.8%)纳入了表型分层。大多数演讲集中在以膀胱为中心的演讲上。男性在IC/BPS临床试验中的代表性不足。与没有行业支持的试验相比,在行业资助的试验中更频繁地报道表型分层(40.5% vs 16.5%, P=0.0031)。2015年AUA指南更新后注册的试验显示更大的表型纳入,尽管这没有统计学意义(26.6%对15.8%)。治疗性试验占试验的大多数。分层在物理治疗和社会心理试验中出现的频率更高,为40%,在药物研究中为34.3%。膀胱内滴注和注射试验的发生率较低,分别为19.6%和13.0%。结论:未能将IC/BPS表型纳入试验设计限制了在现实世界症状变异性背景下评估治疗的能力。弥合这一方法学上的差距对于确保临床研究支持开发更有针对性和更有效的治疗方法至关重要。
{"title":"Phenotype Variability in Interstitial Cystitis Clinical Trial Recruitment.","authors":"Ryan Wong, Emmaline Woodworth, Charles Wood, Sarah A Adelstein, Annah J Vollstedt","doi":"10.1097/SPV.0000000000001759","DOIUrl":"10.1097/SPV.0000000000001759","url":null,"abstract":"<p><strong>Importance: </strong>There is a need to understand phenotype-specific therapies for interstitial cystitis/bladder pain syndrome (IC/BPS) at the clinical trial level to move beyond trial-and-error treatment approaches.</p><p><strong>Objective: </strong>The objective of this study was to characterize IC/BPS clinical trials that incorporate patient phenotype into the eligibility criteria in accordance with the American Urological Association (AUA) guidelines.</p><p><strong>Study design: </strong>Registered IC/BPS clinical trials were identified from ClinicalTrials.gov. Trials were included if they enrolled patients with IC/BPS and addressed pain-related outcomes. Trials were assessed for phenotype recognition and categorized by intervention type, funding source, and registration date relative to the AUA's 2015 IC/BPS guidelines for initial phenotype recognition.</p><p><strong>Results: </strong>Out of 170 trials, 37 (21.8%) included phenotype stratification. The majority focused on bladder-centric presentations. Men were underrepresented in IC/BPS clinical trials. Phenotypic stratification was more frequently reported in industry-funded trials compared with those without industry support (40.5% vs 16.5%, P =0.0031). Trials registered after the 2015 AUA guideline update showed greater phenotype inclusion, though this was not statistically significant (26.6% vs 15.8%). Therapeutic trials comprised the majority of trials. Stratification appeared more often in physical therapy and psychosocial trials at 40% and in drug studies at 34.3%. Intravesical instillation and injection trials showed lower rates at 19.6% and 13.0%, respectively.</p><p><strong>Conclusions: </strong>Failure to incorporate IC/BPS phenotypes into trial design limits the ability to evaluate treatments within the context of real-world symptom variability. Bridging this methodological gap is essential to ensure that clinical research supports the development of more targeted and effective therapies.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145202424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spatial Mapping of Pelvic Anatomy Focused on Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Apical Suspension Prolapse Procedures. 聚焦于阴道自然口腔内内镜手术(vNOTES)根尖悬垂手术的骨盆解剖空间映射。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-19 DOI: 10.1097/SPV.0000000000001752
Dani Zoorob, Adegbenro O J Fakoya, Hosne Ara, Mathew Root, Michael Mahoney, Christopher Menefee, Kristy Waltman, Veronica Lerner

Importance: Comprehensive understanding of anatomic landmarks is essential for safe and successful apical suspension during vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) procedures. However, detailed descriptions of these landmarks remain scarce in the current literature.

Objective: We aimed to delineate the anatomic relationships of key landmarks relevant to apical suspension procedures performed through vNOTES.

Study design: Ten embalmed female cadavers were dissected. A 9.5 cm Alexis retractor from the commercially manufactured vNOTES port was used. Distances were measured from the inner ring of the retractor to the following anatomic structures: the ischial spine (sagittal and transverse planes), S1 root, urethra, trigone, pubic crest, and iliac vessels.

Results: The mean distance from the retractor's inner ring to the ischial spine was 1.0 cm (range: 0.9-1.3, SD: 0.1) sagittally and 3.6 cm (range: 3.0-4.9, SD: 0.6) transversely. The S1 foramen was located 6.4 cm (range: 5.0-8.0, SD: 1.0) from the ring's midpoint. Sagittal measurements revealed a mean distance of 2.6 cm (range: 1.7-3.5, SD: 1.0) from the proximal urethra and 1.9 cm (range: 1.4-3.5, SD: 0.7) from the trigone. The external iliac vessels were 3.2 cm (range: 2.1-4.1, SD: 0.7) from the ring's edge, while the pubic crest was 2.7 cm (range: 1.6-3.3, SD: 0.5) away.

Conclusions: The spatial relationships described in this study provide crucial reference points for surgeons performing apical suspension during vNOTES. Knowledge of these relationships can enhance safety and provide a roadmap for future innovation and the advancement of complex gynecologic interventions.

重要性:在阴道自然腔内窥镜手术(vNOTES)过程中,对解剖学标志的全面理解对于安全和成功的根尖悬吊是必不可少的。然而,在目前的文献中,对这些地标的详细描述仍然很少。目的:我们旨在通过vNOTES描述与根尖悬吊手术相关的关键标志的解剖关系。研究设计:解剖10具经防腐处理的女性尸体。使用商用vNOTES端口的9.5 cm亚历克西斯牵开器。测量牵开器内环到以下解剖结构的距离:坐骨棘(矢状面和横切面)、S1根、尿道、三角区、耻骨和髂血管。结果:牵开器内环距坐骨棘矢状面平均距离为1.0 cm(范围:0.9-1.3,SD: 0.1),横向距离为3.6 cm(范围:3.0-4.9,SD: 0.6)。S1孔位于距环中点6.4 cm(范围:5.0-8.0,SD: 1.0)处。矢状位测量显示,距尿道近端平均距离2.6 cm(范围:1.7-3.5,SD: 1.0),距三角区平均距离1.9 cm(范围:1.4-3.5,SD: 0.7)。髂外血管距环缘3.2 cm(范围:2.1 ~ 4.1,SD: 0.7),耻骨嵴距环缘2.7 cm(范围:1.6 ~ 3.3,SD: 0.5)。结论:本研究描述的空间关系为外科医生在vNOTES中实施根尖悬吊提供了重要的参考点。了解这些关系可以提高安全性,并为未来的创新和复杂妇科干预措施的进步提供路线图。
{"title":"Spatial Mapping of Pelvic Anatomy Focused on Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Apical Suspension Prolapse Procedures.","authors":"Dani Zoorob, Adegbenro O J Fakoya, Hosne Ara, Mathew Root, Michael Mahoney, Christopher Menefee, Kristy Waltman, Veronica Lerner","doi":"10.1097/SPV.0000000000001752","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001752","url":null,"abstract":"<p><strong>Importance: </strong>Comprehensive understanding of anatomic landmarks is essential for safe and successful apical suspension during vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) procedures. However, detailed descriptions of these landmarks remain scarce in the current literature.</p><p><strong>Objective: </strong>We aimed to delineate the anatomic relationships of key landmarks relevant to apical suspension procedures performed through vNOTES.</p><p><strong>Study design: </strong>Ten embalmed female cadavers were dissected. A 9.5 cm Alexis retractor from the commercially manufactured vNOTES port was used. Distances were measured from the inner ring of the retractor to the following anatomic structures: the ischial spine (sagittal and transverse planes), S1 root, urethra, trigone, pubic crest, and iliac vessels.</p><p><strong>Results: </strong>The mean distance from the retractor's inner ring to the ischial spine was 1.0 cm (range: 0.9-1.3, SD: 0.1) sagittally and 3.6 cm (range: 3.0-4.9, SD: 0.6) transversely. The S1 foramen was located 6.4 cm (range: 5.0-8.0, SD: 1.0) from the ring's midpoint. Sagittal measurements revealed a mean distance of 2.6 cm (range: 1.7-3.5, SD: 1.0) from the proximal urethra and 1.9 cm (range: 1.4-3.5, SD: 0.7) from the trigone. The external iliac vessels were 3.2 cm (range: 2.1-4.1, SD: 0.7) from the ring's edge, while the pubic crest was 2.7 cm (range: 1.6-3.3, SD: 0.5) away.</p><p><strong>Conclusions: </strong>The spatial relationships described in this study provide crucial reference points for surgeons performing apical suspension during vNOTES. Knowledge of these relationships can enhance safety and provide a roadmap for future innovation and the advancement of complex gynecologic interventions.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145133214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal Anesthesia for Polyacrylamide Hydrogel Injection: A Randomized Trial. 聚丙烯酰胺水凝胶注射最佳麻醉:一项随机试验。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-19 DOI: 10.1097/SPV.0000000000001757
Neha G Gaddam, Joanna Marantidis, Noha T Ahmed, Rachael D Sussman, Elizabeth T Brown, Alexis A Dieter, Andrew I Sokol, Robert E Gutman, Lee A Richter

Importance: Despite the popularity of urethral bulking with polyacrylamide hydrogel (PAHG) for stress urinary incontinence (SUI)/intrinsic sphincter deficiency (ISD), no studies have assessed optimal anesthetic protocols.

Objectives: To compare pain scores between 2 anesthetic protocols in women undergoing in-office PAHG injection: (1) combined anesthetic [external lidocaine-plus-prilocaine (EMLA) cream, intraurethral lidocaine gel, and lidocaine periurethral block] or (2) topical-only (external EMLA cream and intraurethral lidocaine gel).

Study design: This single-blinded trial randomized women to 1 of 2 anesthetic protocols. The primary outcome was pain reported via a 10-point visual analog scale (VAS). Secondary outcomes included International Consultation on Incontinence Questionnaire-Urinary Incontinence (ICIQ-UI) and Patient Global Impression of Improvement (PGI-I) scores. A safety endpoint of 3 subjects in the topical-only arm requiring unplanned periurethral block to complete the PAHG procedure, and an a priori sample size of 52 subjects was set.

Results: Recruitment stopped at 23 subjects (N=11 combined anesthetic vs. N=12 topical-only) upon meeting the safety endpoint. Mean procedural VAS pain scores were lower with concomitant periurethral block (4.5±2.7 combined anesthetic vs. 7.4±2.3 topical-only; P<0.01). For 3 subjects in the topical-only arm requiring additional anesthesia, VAS pain scores were reduced following periurethral block (10.0±0.0 preblock to 4.0±2.6 postblock; P=0.04). There was no difference between arms in procedure duration, reinjection, or questionnaire scores. Subjects in the combined anesthetic arm were less likely to require post-procedure straight catheterization (0% vs. 33% topical-only; P=0.04).

Conclusions: Use of a periurethral block with topical anesthetics reduced pain scores and improved postprocedure voiding. These findings support using a combined anesthetic protocol for women undergoing in-office PAHG injection.

重要性:尽管聚丙烯酰胺水凝胶(PAHG)尿道填充术用于治疗压力性尿失禁(SUI)/内在括约肌缺陷(ISD)很受欢迎,但没有研究评估最佳麻醉方案。目的:比较两种麻醉方案(1)联合麻醉[外用利多卡因加普利洛卡因(EMLA)乳膏、经尿道利多卡因凝胶和经尿道利多卡因阻滞]或(2)单局部麻醉(外用EMLA乳膏和经尿道利多卡因凝胶)女性在办公室注射PAHG时的疼痛评分。研究设计:该单盲试验将女性随机分为两组麻醉方案中的一组。主要结果是通过10分视觉模拟量表(VAS)报告疼痛。次要结局包括国际尿失禁咨询问卷-尿失禁(ICIQ-UI)和患者总体改善印象(PGI-I)评分。安全终点为仅局部治疗组的3名受试者,需要无计划的尿道周围阻滞来完成PAHG手术,并设置了52名受试者的先验样本量。结果:在达到安全终点后,23名受试者(N=11联合麻醉vs N=12局部麻醉)停止招募。尿道周围阻滞组手术VAS疼痛评分较低(联合麻醉4.5±2.7分,单纯局部麻醉7.4±2.3分)。结论:尿道周围阻滞联合局部麻醉可降低疼痛评分,改善术后排尿。这些发现支持使用联合麻醉方案的妇女接受办公室注射多环芳烃。
{"title":"Optimal Anesthesia for Polyacrylamide Hydrogel Injection: A Randomized Trial.","authors":"Neha G Gaddam, Joanna Marantidis, Noha T Ahmed, Rachael D Sussman, Elizabeth T Brown, Alexis A Dieter, Andrew I Sokol, Robert E Gutman, Lee A Richter","doi":"10.1097/SPV.0000000000001757","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001757","url":null,"abstract":"<p><strong>Importance: </strong>Despite the popularity of urethral bulking with polyacrylamide hydrogel (PAHG) for stress urinary incontinence (SUI)/intrinsic sphincter deficiency (ISD), no studies have assessed optimal anesthetic protocols.</p><p><strong>Objectives: </strong>To compare pain scores between 2 anesthetic protocols in women undergoing in-office PAHG injection: (1) combined anesthetic [external lidocaine-plus-prilocaine (EMLA) cream, intraurethral lidocaine gel, and lidocaine periurethral block] or (2) topical-only (external EMLA cream and intraurethral lidocaine gel).</p><p><strong>Study design: </strong>This single-blinded trial randomized women to 1 of 2 anesthetic protocols. The primary outcome was pain reported via a 10-point visual analog scale (VAS). Secondary outcomes included International Consultation on Incontinence Questionnaire-Urinary Incontinence (ICIQ-UI) and Patient Global Impression of Improvement (PGI-I) scores. A safety endpoint of 3 subjects in the topical-only arm requiring unplanned periurethral block to complete the PAHG procedure, and an a priori sample size of 52 subjects was set.</p><p><strong>Results: </strong>Recruitment stopped at 23 subjects (N=11 combined anesthetic vs. N=12 topical-only) upon meeting the safety endpoint. Mean procedural VAS pain scores were lower with concomitant periurethral block (4.5±2.7 combined anesthetic vs. 7.4±2.3 topical-only; P<0.01). For 3 subjects in the topical-only arm requiring additional anesthesia, VAS pain scores were reduced following periurethral block (10.0±0.0 preblock to 4.0±2.6 postblock; P=0.04). There was no difference between arms in procedure duration, reinjection, or questionnaire scores. Subjects in the combined anesthetic arm were less likely to require post-procedure straight catheterization (0% vs. 33% topical-only; P=0.04).</p><p><strong>Conclusions: </strong>Use of a periurethral block with topical anesthetics reduced pain scores and improved postprocedure voiding. These findings support using a combined anesthetic protocol for women undergoing in-office PAHG injection.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145133208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor re: "The Use of Race in AUGS-Endorsed Risk Calculator". 致编辑的信:“在augs认可的风险计算器中使用种族”。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-01 DOI: 10.1097/SPV.0000000000001714
Caitlin E Carlton
{"title":"Letter to the Editor re: \"The Use of Race in AUGS-Endorsed Risk Calculator\".","authors":"Caitlin E Carlton","doi":"10.1097/SPV.0000000000001714","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001714","url":null,"abstract":"","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":"31 9","pages":"905-906"},"PeriodicalIF":1.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Letter to the Editor: American Urogynecologic Society Best Practice Statement: Evaluation and Counseling of Patients With Pelvic Organ Prolapse. 美国泌尿妇科学会最佳实践声明:盆腔器官脱垂患者的评估和咨询。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-01 DOI: 10.1097/SPV.0000000000001727
Cassandra L Carberry, Paul K Tulikangas, Beri M Ridgeway, Sarah A Collins, Rony A Adam
{"title":"Response to Letter to the Editor: American Urogynecologic Society Best Practice Statement: Evaluation and Counseling of Patients With Pelvic Organ Prolapse.","authors":"Cassandra L Carberry, Paul K Tulikangas, Beri M Ridgeway, Sarah A Collins, Rony A Adam","doi":"10.1097/SPV.0000000000001727","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001727","url":null,"abstract":"","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":"31 9","pages":"909-910"},"PeriodicalIF":1.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Are the Most Popular Articles in Urogynecology and Who Is Disseminating Them? 泌尿妇科最流行的文章是什么,谁在传播它们。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-01 DOI: 10.1097/SPV.0000000000001581
Stephanie Nicole Williams, Jocelyn Fitzgerald

Importance: This research describes which articles published in Urogynecology are garnering the most attention online. Understanding which articles are having the largest impact in the online community has become increasingly important due to the exponential increase in the use of social media on the internet.

Objective: The Altmetric Attention Score (AAS) is a quantitative and qualitative measure of the articles' online attention in social media and news outlets, blogs, and reference managers. The aim of this study was to provide an analysis of those accessing and sharing the 100 most popular articles published in Urogynecology .

Study design: This was a retrospective descriptive analysis. Using Dimensions, a "linked research knowledge system," data about each article's demographics on Twitter and other media sources was extracted from each of the articles within Urogynecology with the highest AAS. No articles were excluded. The articles were categorized by topic and metrics of online sharing were compared among categories.

Results: Fifteen categories were created. Sexual health and education articles had the highest average Altmetric scores per article and reached the highest impressions per article and had the highest average follower count per Twitter user. On average, social justice in medicine had the highest number of tweets per article. Tweets were most often composed by members of the public (58%) compared with health care practitioners (14%), researchers (13%), and science communicators (12%).

Conclusions: Sexual health and education articles had the highest average AAS and impressions on Twitter. We observed a difference in which articles are being shared most among the general public and health care professionals. The general public comprised a majority of those sharing articles online regardless of category. Additionally, there may be a disparity in research, its funding, and online scientific communications within the field of urogynecology.

重要性:这项研究描述了哪些发表在泌尿妇科杂志上的文章在网上获得了最多的关注。由于互联网上社交媒体的使用呈指数增长,了解哪些文章在网络社区中具有最大的影响力变得越来越重要。目的:Altmetric Attention Score (AAS)是一种定量和定性的衡量文章在社交媒体和新闻媒体、博客和参考管理器中的在线关注度的方法。本研究的目的是对那些访问和分享发表在泌尿妇科杂志上的100篇最受欢迎文章的人进行分析。研究设计:回顾性描述性分析。使用Dimensions(一个“关联研究知识系统”),从AAS最高的泌尿妇科的每篇文章中提取出Twitter和其他媒体来源上每篇文章的人口统计数据。没有文章被排除在外。文章按主题分类,并在类别之间比较在线分享的指标。结果:创建了15个类别。性健康和教育类文章在每篇文章的Altmetric平均得分最高,每篇文章的曝光率最高,每个Twitter用户的平均粉丝数最高。平均而言,医学领域的社会正义每篇文章的推文数量最多。与医疗从业者(14%)、研究人员(13%)和科学传播者(12%)相比,推文最常由公众(58%)组成。结论:性健康和教育类文章在Twitter上的平均AAS和印象最高。我们观察到文章在普通公众和卫生保健专业人员之间分享最多的差异。在网上分享文章的人中,绝大多数是普通大众。此外,在泌尿妇科领域的研究、资助和在线科学交流方面可能存在差异。
{"title":"What Are the Most Popular Articles in Urogynecology and Who Is Disseminating Them?","authors":"Stephanie Nicole Williams, Jocelyn Fitzgerald","doi":"10.1097/SPV.0000000000001581","DOIUrl":"10.1097/SPV.0000000000001581","url":null,"abstract":"<p><strong>Importance: </strong>This research describes which articles published in Urogynecology are garnering the most attention online. Understanding which articles are having the largest impact in the online community has become increasingly important due to the exponential increase in the use of social media on the internet.</p><p><strong>Objective: </strong>The Altmetric Attention Score (AAS) is a quantitative and qualitative measure of the articles' online attention in social media and news outlets, blogs, and reference managers. The aim of this study was to provide an analysis of those accessing and sharing the 100 most popular articles published in Urogynecology .</p><p><strong>Study design: </strong>This was a retrospective descriptive analysis. Using Dimensions, a \"linked research knowledge system,\" data about each article's demographics on Twitter and other media sources was extracted from each of the articles within Urogynecology with the highest AAS. No articles were excluded. The articles were categorized by topic and metrics of online sharing were compared among categories.</p><p><strong>Results: </strong>Fifteen categories were created. Sexual health and education articles had the highest average Altmetric scores per article and reached the highest impressions per article and had the highest average follower count per Twitter user. On average, social justice in medicine had the highest number of tweets per article. Tweets were most often composed by members of the public (58%) compared with health care practitioners (14%), researchers (13%), and science communicators (12%).</p><p><strong>Conclusions: </strong>Sexual health and education articles had the highest average AAS and impressions on Twitter. We observed a difference in which articles are being shared most among the general public and health care professionals. The general public comprised a majority of those sharing articles online regardless of category. Additionally, there may be a disparity in research, its funding, and online scientific communications within the field of urogynecology.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":"896-904"},"PeriodicalIF":1.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends of Overactive Bladder and Pharmacologic Treatment Among U.S. Women. 美国女性膀胱过度活动症和药物治疗趋势。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-01 DOI: 10.1097/SPV.0000000000001575
Lauren A King, Jessica E Pruszynski, Clifford Y Wai, Maria E Florian-Rodriguez

Importance: To evaluate and consider how prescribing practices have changed in relation to high-risk overactive bladder (OAB) medications.

Objective: The objective of this study was to evaluate trends in the prevalence of OAB and pharmacologic treatment over time in the United States.

Study design: Data from the National Health and Nutrition Examination Survey (NHANES, 2001-2018, n = 30,478) and the National Ambulatory Medical Care Survey (NAMCS, 2003-2019, n = 251,330) were used to identify women with symptomatic incontinence and overactive bladder (OAB) (NHANES) as well as determine the frequency of prescription use for OAB medications (NHANES and NAMCS) using sampling-based weights. Joinpoint regression was used to determine adjusted annual percent change (APC, adjusting for race, age, body mass index, and insurance status). Trends were assessed overall and by race, age, body mass index, and insurance status.

Results: The prevalence of OAB was 31.2% in the final survey year of NHANES (2017-2018). Women aged >65 years had the highest prevalence of OAB at 54% compared with other age groups. There was an overall increase in OAB (APC 1.24 [0.64, 1.84], P  = 0.002) over time. Overall, only 3.5% of patients with symptoms of OAB reported pharmacologic treatment in NHANES. The NAMCS demonstrated a significant decrease in anticholinergic prescriptions from 2003 until 2019 (APC -6.44 [-9.77, -2.98], P  = 0.001). However, in NHANES, there was no significant change in anticholinergic use (APC 0.62 [-20.2, 26.8], P  = 0.944). There was a stable prevalence of β 3 -adrenergic agonist prescriptions since they were introduced to market (APC 0.65 [-2.24, 3.62], P  = 0.616).

Conclusion: This study demonstrates an increasing prevalence of OAB and highlights the likely undertreatment of symptomatic patients. The high and increasing prevalence coupled with the relative undertreatment of OAB underscores the importance of screening for this condition.

重要性:评估和思考高风险膀胱过度活动症(OAB)药物处方的变化:评估并考虑高风险膀胱过度活动症(OAB)药物处方的变化情况:本研究旨在评估美国膀胱过度活动症患病率和药物治疗随时间推移的趋势:研究设计:采用全国健康与营养调查(NHANES,2001-2018 年,n = 30,478 人)和全国流动医疗护理调查(NAMCS,2003-2019 年,n = 251,330 人)的数据来识别有症状尿失禁和膀胱过度活动症(OAB)的女性(NHANES),并使用基于抽样的权重来确定 OAB 药物处方的使用频率(NHANES 和 NAMCS)。采用连接点回归法确定调整后的年百分比变化(APC,根据种族、年龄、体重指数和保险状况进行调整)。对总体趋势以及不同种族、年龄、体重指数和保险状况的趋势进行了评估:在 NHANES 的最后调查年(2017-2018 年),OAB 患病率为 31.2%。与其他年龄组相比,年龄大于 65 岁的女性 OAB 患病率最高,为 54%。随着时间的推移,OAB的患病率总体呈上升趋势(APC 1.24 [0.64, 1.84],P = 0.002)。总体而言,在 NHANES 调查中,仅有 3.5% 有 OAB 症状的患者报告接受过药物治疗。NAMCS 显示,从 2003 年到 2019 年,抗胆碱能药物处方显著减少(APC -6.44 [-9.77, -2.98],P = 0.001)。然而,在 NHANES 中,抗胆碱能药物的使用没有明显变化(APC 0.62 [-20.2, 26.8],P = 0.944)。自β3-肾上腺素能激动剂上市以来,其处方使用率保持稳定(APC 0.65 [-2.24, 3.62],P = 0.616):这项研究表明,OAB 的患病率在不断上升,同时也凸显出对有症状患者的治疗可能不足。OAB 的高患病率和不断增加的患病率以及相对较少的治疗突出了筛查这种疾病的重要性。
{"title":"Trends of Overactive Bladder and Pharmacologic Treatment Among U.S. Women.","authors":"Lauren A King, Jessica E Pruszynski, Clifford Y Wai, Maria E Florian-Rodriguez","doi":"10.1097/SPV.0000000000001575","DOIUrl":"10.1097/SPV.0000000000001575","url":null,"abstract":"<p><strong>Importance: </strong>To evaluate and consider how prescribing practices have changed in relation to high-risk overactive bladder (OAB) medications.</p><p><strong>Objective: </strong>The objective of this study was to evaluate trends in the prevalence of OAB and pharmacologic treatment over time in the United States.</p><p><strong>Study design: </strong>Data from the National Health and Nutrition Examination Survey (NHANES, 2001-2018, n = 30,478) and the National Ambulatory Medical Care Survey (NAMCS, 2003-2019, n = 251,330) were used to identify women with symptomatic incontinence and overactive bladder (OAB) (NHANES) as well as determine the frequency of prescription use for OAB medications (NHANES and NAMCS) using sampling-based weights. Joinpoint regression was used to determine adjusted annual percent change (APC, adjusting for race, age, body mass index, and insurance status). Trends were assessed overall and by race, age, body mass index, and insurance status.</p><p><strong>Results: </strong>The prevalence of OAB was 31.2% in the final survey year of NHANES (2017-2018). Women aged >65 years had the highest prevalence of OAB at 54% compared with other age groups. There was an overall increase in OAB (APC 1.24 [0.64, 1.84], P  = 0.002) over time. Overall, only 3.5% of patients with symptoms of OAB reported pharmacologic treatment in NHANES. The NAMCS demonstrated a significant decrease in anticholinergic prescriptions from 2003 until 2019 (APC -6.44 [-9.77, -2.98], P  = 0.001). However, in NHANES, there was no significant change in anticholinergic use (APC 0.62 [-20.2, 26.8], P  = 0.944). There was a stable prevalence of β 3 -adrenergic agonist prescriptions since they were introduced to market (APC 0.65 [-2.24, 3.62], P  = 0.616).</p><p><strong>Conclusion: </strong>This study demonstrates an increasing prevalence of OAB and highlights the likely undertreatment of symptomatic patients. The high and increasing prevalence coupled with the relative undertreatment of OAB underscores the importance of screening for this condition.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":"871-881"},"PeriodicalIF":1.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Age on Perioperative Complications After Obliterative Vaginal Surgery. 年龄对阴道闭锁手术围手术期并发症的影响
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-01 DOI: 10.1097/SPV.0000000000001579
Erin E Mowers, Laura G Vargas, Jonathan P Shepherd, Michael J Bonidie, Mary F Ackenbom

Importance: Obliterative vaginal surgery is often reserved for older patients with prolapse, but the effect of age as an independent risk factor for perioperative complications in this cohort is poorly understood.

Objective: The aim of this study was to assess the association between age and perioperative complications in women undergoing obliterative vaginal surgery.

Study design: This was a retrospective cohort study that included 371 patients undergoing colpocleisis between 2010 and 2013 at a single academic medical center. Seventy demographic and clinical variables, including complications within 12 weeks of surgery, were analyzed. The χ 2 and Fisher exact tests were used for categorical variables. Student t and Mann-Whitney U tests were used for continuous variables. Univariate logistic regression was performed to identify predictors of perioperative complications, and candidate variables with P  < 0.2 were used in multivariate logistic regression.

Results: The mean patient age was 75.4 ± 6.4 years (range, 59-94 years). One hundred ten (29.7%) patients experienced at least 1 complication, the most common of which was urinary tract infection (n = 47, 12.7%). In the final multivariable model, only age (odds ratio, 1.05 per year; 95% confidence interval, 1.01-1.08) remained a significant predictor of perioperative complications. A cut point of age ≥70.5 years maximized sensitivity and specificity for predicting complications.

Conclusions: Among women undergoing obliterative vaginal surgery, age is a predictor of perioperative complications. Each increasing year of age increases the complication likelihood by 1.05-fold, such that an 85-year-old woman is 1.05^20 or 2.65 times more likely than a 65-year-old woman to have a complication. A cut point of ≥70.5 years best predicted complications. Despite this association, severe perioperative complications following obliterative surgery are rare.

重要性:阴道闭锁手术通常保留给年龄较大的脱垂患者,但对于年龄作为围手术期并发症独立风险因素的影响却知之甚少:本研究旨在评估接受阴道闭锁手术妇女的年龄与围手术期并发症之间的关系:这是一项回顾性队列研究,纳入了 2010 年至 2013 年期间在一家学术医疗中心接受阴道闭锁手术的 371 名患者。研究分析了 70 个人口统计学和临床变量,包括手术后 12 周内的并发症。分类变量采用χ2检验和费雪精确检验。连续变量采用学生 t 检验和 Mann-Whitney U 检验。进行单变量逻辑回归以确定围手术期并发症的预测因素,P<0.2的候选变量用于多变量逻辑回归:患者平均年龄为 75.4 ± 6.4 岁(59-94 岁)。110名患者(29.7%)至少出现过一种并发症,其中最常见的是尿路感染(47人,12.7%)。在最终的多变量模型中,只有年龄(几率比,每年 1.05;95% 置信区间,1.01-1.08)仍然是围手术期并发症的重要预测因素。年龄≥70.5岁是预测并发症的最大灵敏度和特异性切点:结论:在接受阴道闭锁手术的女性中,年龄是围手术期并发症的预测因素。年龄每增加一岁,发生并发症的可能性就会增加 1.05 倍,因此 85 岁妇女发生并发症的可能性是 65 岁妇女的 1.05^20 或 2.65 倍。≥70.5岁是预测并发症的最佳切点。尽管存在这种关联,但闭塞手术后出现严重围手术期并发症的情况并不多见。
{"title":"Impact of Age on Perioperative Complications After Obliterative Vaginal Surgery.","authors":"Erin E Mowers, Laura G Vargas, Jonathan P Shepherd, Michael J Bonidie, Mary F Ackenbom","doi":"10.1097/SPV.0000000000001579","DOIUrl":"10.1097/SPV.0000000000001579","url":null,"abstract":"<p><strong>Importance: </strong>Obliterative vaginal surgery is often reserved for older patients with prolapse, but the effect of age as an independent risk factor for perioperative complications in this cohort is poorly understood.</p><p><strong>Objective: </strong>The aim of this study was to assess the association between age and perioperative complications in women undergoing obliterative vaginal surgery.</p><p><strong>Study design: </strong>This was a retrospective cohort study that included 371 patients undergoing colpocleisis between 2010 and 2013 at a single academic medical center. Seventy demographic and clinical variables, including complications within 12 weeks of surgery, were analyzed. The χ 2 and Fisher exact tests were used for categorical variables. Student t and Mann-Whitney U tests were used for continuous variables. Univariate logistic regression was performed to identify predictors of perioperative complications, and candidate variables with P  < 0.2 were used in multivariate logistic regression.</p><p><strong>Results: </strong>The mean patient age was 75.4 ± 6.4 years (range, 59-94 years). One hundred ten (29.7%) patients experienced at least 1 complication, the most common of which was urinary tract infection (n = 47, 12.7%). In the final multivariable model, only age (odds ratio, 1.05 per year; 95% confidence interval, 1.01-1.08) remained a significant predictor of perioperative complications. A cut point of age ≥70.5 years maximized sensitivity and specificity for predicting complications.</p><p><strong>Conclusions: </strong>Among women undergoing obliterative vaginal surgery, age is a predictor of perioperative complications. Each increasing year of age increases the complication likelihood by 1.05-fold, such that an 85-year-old woman is 1.05^20 or 2.65 times more likely than a 65-year-old woman to have a complication. A cut point of ≥70.5 years best predicted complications. Despite this association, severe perioperative complications following obliterative surgery are rare.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":" ","pages":"887-895"},"PeriodicalIF":1.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Asymptomatic Bacteriuria in Adult Female Populations. 成年女性人群无症状菌尿的处理。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-01 DOI: 10.1097/SPV.0000000000001731
Nazema Y Siddiqui, A Lenore Ackerman, Sonali D Advani, Toby Chai, Christine Chu, Kerac Falk, Sarah E S Jeney, Megan Bradley

Abstract: This Clinical Consensus Statement on the management of asymptomatic bacteriuria (ASB) in adult females reflects statements drafted by content experts within the American Urogynecologic Society Bacteriuria Writing Group. The writing group created 32 clinically relevant topic questions, which were collapsed into 30 questions due to thematic overlap. The group used a modified Delphi process to evaluate the statements for consensus. Eight out of 30 questions did not reach consensus after the first Delphi round. Based on group discussion, several questions were restructured or omitted and 25 were retained. Consensus was reached on all 25 statements after 2 further rounds of discussion. Evidence summaries were developed from a structured literature search and are presented with each topic question and statement. Overall, ASB is common and increases with age in the female population. Treatment of ASB is thought to confer more harm than benefit in most women. For women with chronic lower urinary tract symptoms and bacteriuria, an acute change in symptoms should be evaluated with urinalysis and urine culture to guide decision making for antimicrobial therapy.

摘要:本关于成年女性无症状细菌尿(ASB)管理的临床共识声明反映了美国泌尿妇科学会细菌尿写作小组内容专家起草的声明。写作组创建了32个临床相关主题问题,由于主题重叠,这些问题被压缩为30个问题。该小组使用了一个改进的德尔菲过程来评估共识的陈述。在第一轮德尔菲之后,30个问题中有8个没有达成共识。在小组讨论的基础上,对若干问题进行了调整或省略,保留了25个问题。经过进一步两轮讨论,就所有25项发言达成了协商一致意见。证据摘要从结构化的文献检索中得到,并与每个主题问题和陈述一起呈现。总的来说,ASB在女性人群中很常见,并且随着年龄的增长而增加。对大多数女性来说,ASB的治疗被认为弊大于利。对于患有慢性下尿路症状和细菌尿的女性,应通过尿液分析和尿液培养来评估症状的急性变化,以指导抗菌药物治疗的决策。
{"title":"Management of Asymptomatic Bacteriuria in Adult Female Populations.","authors":"Nazema Y Siddiqui, A Lenore Ackerman, Sonali D Advani, Toby Chai, Christine Chu, Kerac Falk, Sarah E S Jeney, Megan Bradley","doi":"10.1097/SPV.0000000000001731","DOIUrl":"10.1097/SPV.0000000000001731","url":null,"abstract":"<p><strong>Abstract: </strong>This Clinical Consensus Statement on the management of asymptomatic bacteriuria (ASB) in adult females reflects statements drafted by content experts within the American Urogynecologic Society Bacteriuria Writing Group. The writing group created 32 clinically relevant topic questions, which were collapsed into 30 questions due to thematic overlap. The group used a modified Delphi process to evaluate the statements for consensus. Eight out of 30 questions did not reach consensus after the first Delphi round. Based on group discussion, several questions were restructured or omitted and 25 were retained. Consensus was reached on all 25 statements after 2 further rounds of discussion. Evidence summaries were developed from a structured literature search and are presented with each topic question and statement. Overall, ASB is common and increases with age in the female population. Treatment of ASB is thought to confer more harm than benefit in most women. For women with chronic lower urinary tract symptoms and bacteriuria, an acute change in symptoms should be evaluated with urinalysis and urine culture to guide decision making for antimicrobial therapy.</p>","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":"31 9","pages":"827-845"},"PeriodicalIF":1.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accommodating Surgical Learners. 适应外科学习者。
IF 1.2 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-01 DOI: 10.1097/SPV.0000000000001707
Geoffrey W Cundiff
{"title":"Accommodating Surgical Learners.","authors":"Geoffrey W Cundiff","doi":"10.1097/SPV.0000000000001707","DOIUrl":"https://doi.org/10.1097/SPV.0000000000001707","url":null,"abstract":"","PeriodicalId":75288,"journal":{"name":"Urogynecology (Hagerstown, Md.)","volume":"31 9","pages":"846-848"},"PeriodicalIF":1.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urogynecology (Hagerstown, Md.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1